Who
Shane Thomas Gleason
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, InspireMD.
In numbers
- Trades disclosed
- 58
- Buys
- 0
- Sells
- 24
- Bought
- $0
- Sold
- $578K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 17 May 2023
- Last trade
- 19 May 2026
- Last filed
- 21 May 2026
Companies traded
Activity over time
1 Jan 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 May 2026filed 21 May 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $23K22,778 at $1.01 | filing |
| 19 May 2026filed 21 May 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $23K22,778 at $1.01 | filing |
| 2 Feb 2026filed 21 May 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $4,6762,941 at $1.59 | filing |
| 2 Feb 2026filed 21 May 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $4,6762,941 at $1.59 | filing |
| 2 Feb 2026filed 2 Feb 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $3,2082,000 at $1.60 | filing |
| 2 Feb 2026filed 2 Feb 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $3,2002,000 at $1.60 | filing |
| 30 Jan 2026filed 2 Feb 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $4,7272,900 at $1.63 | filing |
| 30 Jan 2026filed 2 Feb 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $4,7302,900 at $1.63 | filing |
| 29 Jan 2026filed 2 Feb 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $8,2505,000 at $1.65 | filing |
| 29 Jan 2026filed 2 Feb 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $8,2505,000 at $1.65 | filing |
| 28 Jan 2026filed 2 Feb 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $20K12,395 at $1.65 | filing |
| 28 Jan 2026filed 2 Feb 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $20K12,395 at $1.65 | filing |
| 27 Jan 2026filed 2 Feb 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $7,9564,781 at $1.66 | filing |
| 27 Jan 2026filed 2 Feb 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $7,9364,781 at $1.66 | filing |
| 22 Jan 2026filed 2 Feb 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $13K8,411 at $1.57 | filing |
| 22 Jan 2026filed 2 Feb 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $13K8,411 at $1.57 | filing |
| 21 Jan 2026filed 2 Feb 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $29K17,593 at $1.62 | filing |
| 21 Jan 2026filed 2 Feb 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $29K17,593 at $1.62 | filing |
| 20 Jan 2026filed 2 Feb 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $4,7102,955 at $1.59 | filing |
| 20 Jan 2026filed 2 Feb 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Sold | $4,6982,955 at $1.59 | filing |
News
No headline names them, or the companies they trade most, lately.